# Adia MED of Winter Park LLC Autism Spectrum Disorder Research Study

> **NCT07304440** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Adia Med of Winter Park LLC** · enrollment: 100 (estimated)

## Conditions studied

- Autism Spectrum Disorder
- Autism
- ASD
- Autism Spectrum Disorder (ASD)

## Interventions

- **BIOLOGICAL:** Umbilical Cord Blood-Derived Stem Cells and Exosomes
- **DRUG:** Glutathione

## Key facts

- **NCT ID:** NCT07304440
- **Lead sponsor:** Adia Med of Winter Park LLC
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2026-05-01
- **Primary completion:** 2028-06-15
- **Final completion:** 2028-06-15
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07304440

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07304440, "Adia MED of Winter Park LLC Autism Spectrum Disorder Research Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07304440. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*